Providing the Right Information on Target Therapy to the Oncology Community
Sanjiv S. Agarwala, MD
Video Categories: Targeted Therapies
Maryann Wahmann provides resources for neuroendocrine cancers.
Dr. Ajai Chari talks about risk-based treatment for myeloma as the beginning of personalized medicine in the field. The 2 most recent advances are the increased use of proteasome inhibitors for those with the 4;14 translocation and treating those identified with high molecular risk more aggressively.